APA (7th ed.) Citation

C, Y., F, K., W, M., M, D., X, H., S, W., . . . J, L. (2021). Minimum Alveolar Concentration-Awake of Sevoflurane is Decreased in Patients with Parkinson’s Disease: An Up-and-Down Sequential Allocation Trial. Dove Medical Press.

Chicago Style (17th ed.) Citation

C, Yang, Kang F, Meng W, Dong M, Huang X, Wang S, Zuo Z, and Li J. Minimum Alveolar Concentration-Awake of Sevoflurane Is Decreased in Patients with Parkinson’s Disease: An Up-and-Down Sequential Allocation Trial. Dove Medical Press, 2021.

MLA (8th ed.) Citation

C, Yang, et al. Minimum Alveolar Concentration-Awake of Sevoflurane Is Decreased in Patients with Parkinson’s Disease: An Up-and-Down Sequential Allocation Trial. Dove Medical Press, 2021.